Argyle Capital Management Inc. Pfizer Inc Transaction History

Argyle Capital Management Inc.

$250 Million
Q4 2024

A detailed history of Argyle Capital Management Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Argyle Capital Management Inc. holds 134,806 shares of PFE stock, worth $3.55 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares

134,806

Previous 127,486 5.74%

Holding current value

$3.55 Million

Previous $3.69 Million 3.06%

% of portfolio

1.43%

Previous 1.49%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$24.8 - $30.19 $181,536 - $220,990	7,320 Added 5.74%	134,806 $3.58 Million
Q3 2024 Oct 25, 2024	SELL	$27.7 - $31.39 $140,854 - $159,618	-5,085 Reduced 3.84%	127,486 $3.69 Million
Q2 2024 Jul 29, 2024	BUY	$25.26 - $29.6 $195,133 - $228,660	7,725 Added 6.19%	132,571 $3.71 Million
Q1 2024 Apr 29, 2024	BUY	$25.89 - $29.73 $195,806 - $224,847	7,563 Added 6.45%	124,846 $3.46 Million
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $520,431 - $675,982	-19,917 Reduced 14.52%	117,283 $3.38 Million
Q2 2023 Jul 27, 2023	SELL	$36.12 - $41.79 $148,344 - $171,631	-4,107 Reduced 2.91%	137,200 $5.03 Million
Q4 2022 Feb 06, 2023	SELL	$41.75 - $54.5 $14,403 - $18,802	-345 Reduced 0.24%	141,307 $7.24 Million
Q3 2022 Oct 21, 2022	BUY	$43.76 - $53.42 $8,752 - $10,684	200 Added 0.14%	141,652 $6.2 Million
Q2 2022 Jul 20, 2022	SELL	$46.53 - $55.17 $58,348 - $69,183	-1,254 Reduced 0.88%	141,452 $7.42 Million
Q1 2022 Apr 27, 2022	SELL	$45.75 - $56.69 $296,963 - $367,974	-6,491 Reduced 4.35%	142,706 $7.39 Million
Q4 2021 Jan 25, 2022	SELL	$41.32 - $61.25 $99,168 - $147,000	-2,400 Reduced 1.58%	149,197 $8.81 Million
Q3 2021 Oct 25, 2021	SELL	$39.25 - $50.42 $11,775 - $15,126	-300 Reduced 0.2%	151,597 $6.52 Million
Q3 2020 Oct 27, 2020	SELL	$31.75 - $37.25 $50,800 - $59,600	-1,600 Reduced 1.04%	151,897 $5.58 Million
Q2 2020 Jul 22, 2020	SELL	$30.12 - $36.54 $10,060 - $12,204	-334 Reduced 0.22%	153,497 $5.02 Million
Q1 2020 Apr 27, 2020	BUY	$27.03 - $38.62 $9,055 - $12,937	335 Added 0.22%	153,831 $5.02 Million
Q4 2019 Jan 24, 2020	SELL	$32.92 - $37.36 $13,168 - $14,944	-400 Reduced 0.26%	153,496 $6.01 Million
Q3 2019 Oct 25, 2019	BUY	$32.49 - $42.13 $22,743 - $29,491	700 Added 0.46%	153,896 $5.53 Million
Q2 2019 Jul 25, 2019	BUY	$36.98 - $41.52 $14,791 - $16,608	400 Added 0.26%	153,196 $6.64 Million
Q4 2018 Jan 28, 2019	SELL	$38.47 - $43.86 $76,940 - $87,720	-2,000 Reduced 1.29%	152,796 $6.67 Million
Q3 2018 Oct 26, 2018	SELL	$34.47 - $41.81 $10,030 - $12,166	-291 Reduced 0.19%	154,796 $6.82 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $5,837 - $6,223	-177 Reduced 0.11%	155,087 $5.63 Million
Q1 2018 Apr 25, 2018	SELL	$31.91 - $37.02 $96,017 - $111,393	-3,009 Reduced 1.9%	155,264 $5.51 Million
Q4 2017 Jan 25, 2018	SELL	$33.26 - $35.29 $36,586 - $38,819	-1,100 Reduced 0.69%	158,273 $5.73 Million
Q3 2017 Oct 26, 2017	BUY	$31.0 - $34.15 $4.94 Million - $5.44 Million	159,373	159,373 $5.69 Million

Others Institutions Holding PFE

# of Institutions

3,354

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argyle Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argyle Capital Management Inc. with notifications on news.

Account

Argyle Capital Management Inc. Pfizer Inc Transaction History